Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

January 19, 2024

https://www.prnewswire.com/news-releases/elevation-oncology-announces-program-updates-and-upcoming-2024-milestones-302026858.html

— Update from Ongoing Phase 1 Clinical Trial of EO-3021 Now Expected Mid-2024 —
— Expanding EO-3021 Clinical Development Program to Include Combination Strategy — 
— Announcing HER3-targeting ADC as Second Pipeline Program; Development Candidate Nomination in 2024–
— Entering 2024 in Strong Financial Position, with Cash into 2H 2025 —

Read more at prnewswire.com

Related news for (ELEV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.